Read + Share
Su PL, Tsai JS, Yang SC, Wu YL, et al. Survival benefit of osimertinib combination therapy in patients with
T790M-positive non-small-cell lung cancer refractory to osimertinib treatment. Lung Cancer 2021;158:137-145.
PMID: 34214933
|
 |
|
Su PL, Tsai JS, Yang SC, Wu YL, et al. Survival benefit of osimertinib combination therapy in patients with
T790M-positive non-small-cell lung cancer refractory to osimertinib treatment. Lung Cancer 2021;158:137-145.
PMID: 34214933
|
|
|
|